Teriparatide reduces the risk of developing moderate or severe back pain in women with postmenopausal osteoporosis

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1501, 2005-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Teriparatide reduces fracture risk in postmenopausal osteoporosis

By  

Inpharma, Vol. 1, Iss. 1288, 2001-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Oral dexamethasone reduces pain in children with moderate-to-severe pharyngitis

By  

Inpharma, Vol. 1, Iss. 1487, 2005-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Treatment of osteoporosis and reduction in risk of invasive breast cancer in postmenopausal women with raloxifene

By Ko Seung Sang   Jordan V Craig  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 4, 2011-03 ,pp. : 657-674

Informa Healthcare

Access to resources Recommend Favorite

Treatment of osteoporosis and reduction in risk of invasive breast cancer in postmenopausal women with raloxifene

By  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 7, 2012-05 ,pp. : 1081-1081

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological Management of Severe Postmenopausal Osteoporosis

By Gaudio Agostino   Morabito Nancy  

Drugs & Aging, Vol. 22, Iss. 5, 2005-01 ,pp. : 405-417

Adis International

Access to resources Recommend Favorite